Keyphrases
Induced Apoptosis
100%
Multiple Myeloma
100%
CIAP1
100%
Smac Mimetics
100%
AZD5582
100%
Inhibitor of Apoptosis Proteins
42%
IAP Inhibitor
42%
Combination Therapy
28%
Interleukin-6
28%
Synergistic Effect
28%
Monotherapy
28%
LCL161
28%
CIAP2
28%
Apoptosis
14%
Overexpression
14%
Poor Prognosis
14%
Binding Activity
14%
Conventional Therapy
14%
NF-B
14%
Anti-apoptotic
14%
Direct Binding
14%
High Affinity
14%
Clinical Setting
14%
Myeloma Cells
14%
Positive Regulator
14%
Caspase
14%
JAK-STAT Pathway
14%
U266
14%
New Treatment Options
14%
EC50
14%
Inhibiting Activity
14%
Carfilzomib
14%
Cell Growth Inhibition
14%
Binding Potency
14%
Antiproliferation
14%
RPMI8226
14%
Pharmacology, Toxicology and Pharmaceutical Science
Multiple Myeloma
100%
Combination Therapy
66%
Interleukin 6
66%
Monotherapy
66%
N [1 Cyclohexyl 2 [2 [4 (4 Fluorobenzoyl) 2 Thiazolyl] 1 Pyrrolidinyl] 2 Oxoethyl] 2 (Methylamino)propanamide
66%
Antiapoptotic
33%
Caspase
33%
Carfilzomib
33%
Inhibitor of Apoptosis Protein
33%
Apoptosis Inhibitor
33%
EC50
33%